Identification of a new commonly deleted region within a 2-cM interval of chromosome 11p11 in breast cancers

European Journal of Cancer

Volumn 34, Issue 3, 1998, Pages 417-421

  Nakata, T ^a   Yoshimoto, M ^b   Kasumi, F ^b   Akiyama, F ^b   Sakamoto, G ^b   Nakamura, Y ^c   M, Emi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b CANCER INSTITUTE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Breast cancer; Chromosome 11p; Loss of heterozygosity; Progesterone receptor; Tumour suppressor gene

Indexed keywords

DNA; PROGESTERONE RECEPTOR;

ALLELE; ARTICLE; BREAST CANCER; CHROMOSOME 11P; CHROMOSOME DELETION; CONTROLLED STUDY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AUTORADIOGRAPHY; BREAST NEOPLASMS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; GENE DELETION; HUMANS; LOSS OF HETEROZYGOSITY; RECEPTORS, PROGESTERONE;

EID: 0032007167     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)10153-8     Document Type: Article

References (28)

1. 1. Devilee P, van den Broek M, Kuipers-Dijkshoorn N, et al. At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics 1989, 5, 554-560.
2. 2. Andersen TI, Gaustad A, Ottestad L, et al. Genetic alterations of the tumor suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chrom Cancer 1992, 4, 113-121.
3. 3. Deng G, Chen L-C, Schott DR, et al. Loss of heterozygosity and p53 gene mutations in breast cancer. Cancer Res 1994, 54, 499-505.
4. 4. Sato T, Tanigami A, Yamakawa K, et al. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 1990, 50, 7184-7189.
5. 5. Theillet C, Lidereau R, Escot C, et al. Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas. Cancer Res 1986, 46, 4776-4781.
6. 6. Ali IU, Lidereau R, Theillet C, Callahan R. Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia. Science 1987, 238, 185-188.
7. 7. Mackay J, Elder PA, Porteous DJ, et al. Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumor and oestrogen receptor level. Br J Cancer 1988, 58, 710-714.
8. 8. Winqvist R, Mannermaa A, Alavaikko M, et al. Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors. Cancer Res 1993, 53, 4486-4488.
9. 9. Gudmundsson J, Barkardottir RB, Eiriksdottir G, et al. Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. Br J Cancer 1995, 72, 696-701.
10. 10. Winqvist R, Hampton GM, Mannermaa A, et al. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res 1995, 55, 2660-2664.
11. 11. Negrini M, Rasio D, Hampton GM, et al. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. Cancer Res 1995, 55, 3003-3007.
12. 12. Hampton GN, Mannermaa A, Winqvist R, et al. Loss of heterozygosity in sporadic human breast carcinoma: a commom region between 11q22 and 11q23.3. Cancer Res 1994, 54, 4586-4589.
13. 13. Bepler G, Garcia-Blanco MA. Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer. Proc Natl Acad Sci USA 1994, 91, 5513-5517.
14. 14. Henry I, Grandjouan S, Coullin D, et al. Tumor-specific loss of 11p15.5 alleles in del11p13 Wilms' tumor and in familial adrenocortical carcinoma. Proc Natl Acad USA 1989, 86, 3247-3251.
15. 15. Byrne JA, Simms LA, Little MH, Algar EM, Smith PJ. Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver. Genes Chrom Cancer 1993, 8, 104-111.
16. 16. Viel A, Giannini F, Tumiotto L, Sopracordevole F, Visentin M, Boiocchi M. Chromosome localisation of two putative 11p oncosuppressor genes involved in human ovarian tumors. Br J Cancer 1992, 66, 1030-1036.
17. 17. Sonoda Y, Iizuka M, Yasuda J, et al. Loss of heterozygosity at 11p15 in malignant glioma. Cancer Res 1995, 55, 2166-2168.
18. 18. Baffa R, Negrini M, Mandes B, et al. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res 1996, 56, 268-272.
19. 19. Foulkes WD, Campbell G, Stamp GWH, Trowsdale J. Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer. Br J Cancer 1993, 67, 268-273.
20. 20. Keldysh PL, Dragani TA, Fleishman EW, et al. 11q deletions in human colorectal carcinoma: cytogenetics and restriction fragment length polymorphism analysis. Genes Chrom Cancer 1993, 6, 45-50.
21. 21. Tomlinson IPM, Gammac AJ, Strickland JE, et al. Loss of heterozygosity in malignant melanoma at loci on chromosome 11 and 17 implicated in the pathogenesis of other cancers. Genes Chrom Cancer 1993, 7, 169-172.
22. 22. Hampton GM, Penny LA, Baergen RN, et al. Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor suppressor gene at 11q22-24. Proc Natl Acad Sci USA 1994, 91, 6953-6957.
23. 23. Gyapay G, Morissette J, Vignal A, et al. The 1993-94 Généthon human genetic map. Nature Genet 1994, 7, 246-339.
24. 24. Negrini M, Sabbioni S, Possati L, et al. Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11. Cancer Res 1994, 154, 1331-1336.
25. 25. Ichikawa T, Ichikawa Y, Dong J, et al. Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res 1990, 52, 3486-3490.
26. 26. Dong J-T, Lamb P, Rinker-Schaeffer CW, et al. KAI1, metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995, 268, 884-886.
27. 27. Adachi M, Taki T, Ieki Y, Huang C-L, Higashiyama M, Miyake M. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 1996, 56, 1751-1755.
28. 28. Coleman WB, McCullough KD, Esch GL, et al. Suppression of the tumorigenic phenotype of a rat liver epithelial tumor cell line by the p11.2-p12 region of human chromosome 11. Mol Carcinog 1995, 13, 220-232.